Sarah Bertino

Sarah Bertino, PhD has a diverse work experience that spans various roles in the corporate development and strategy field, as well as in academia. Sarah most recently served as the Senior Director of Corporate Development and Strategy at TScan Therapeutics, starting in February 2022. Prior to this, they worked as the Director of Corporate Development and Strategy at the same company from March 2020 to March 2022. Sarah also held the position of Associate Director of Business Development at TScan Therapeutics from November 2018 to March 2020. Before joining TScan Therapeutics, they worked as a Senior Consultant and Consultant at ClearView Healthcare Partners from August 2015 to November 2018. Additionally, they have experience at Yale University, where they served as a Consultant on the YGCC Pro-bono Consulting Team from March 2014 to May 2015, and as the YGCC Senior Vice President of External Affairs from March 2014 to March 2015. Prior to their work at Yale, they held teaching and research positions at Yale University and Hamilton College, where they worked as a Course Instructor and Teaching Assistant in the field of biology. Overall, Sarah Bertino, PhD has a strong background in corporate development and strategy, with experience in various roles and a solid academic foundation.

Sarah Bertino, PhD, pursued their education with a strong focus on the field of biology. Sarah completed their Bachelor of Arts degree in Biochemistry and Molecular Biology from Hamilton College from 2005 to 2009. Following their undergraduate studies, they enrolled at Yale University from 2009 to 2015, where they obtained their PhD in Immunobiology.